When laboratory results and clinical findings don't match, careful examination is required.
A case report illustrates the importance of carefully evaluating the diagnosis when laboratory results do not match up with clinical signs and symptoms.1 It describes how results of a complete blood count for a girl aged 5 years, whose parents were concerned about her short stature, confirmed a diagnosis of thrombocytopenia. However, the child had no personal or family history of bleeding diathesis, and the blood test revealed many small platelet clumps, which were highly suggestive of ethylenediaminetetraacetic acid (EDTA)-dependent pseudothrombocytopenia. A new blood sample was divided into an EDTA microtainer and a citrate container for immediate testing. Small platelet clumps again were seen in the EDTA but not in the citrate sample. This and other blood sample findings supported the diagnosis of EDTA-dependent pseudothrombocytopenia. This condition is a laboratory artifact caused by the presence of antiplatelet antibodies in the patient’s serum.
Thoughts from Dr. Farber
Remember this pearl should this situation ever come up. More importantly, no matter how much faith you may put in lab testing, remember that an unexpected finding does not automatically mean you missed something on your history and examination; the error may lie in the technology.
Reference
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.